{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:37:00Z","timestamp":1775612220221,"version":"3.50.1"},"reference-count":22,"publisher":"The Japanese Society of Nuclear Cardiology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.17996\/anc.24-00001","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T22:15:08Z","timestamp":1714515308000},"page":"23-28","source":"Crossref","is-referenced-by-count":4,"title":["A Quantitative Diagnostic Method Using &lt;sup&gt;99m&lt;\/sup&gt;Tc-pyrophosphate Lateral Planar Images to Distinguish Between Transthyretin Amyloid Cardiomyopathy and False-Positive Images Due to Blood Pools"],"prefix":"10.17996","volume":"10","author":[{"given":"Junko","family":"Hara","sequence":"first","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honami","family":"Kobiyama","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yamakuni","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Suenaga","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Muto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyasu","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Oikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7364","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2021; 42: 1554&ndash;68.","DOI":"10.1093\/eurheartj\/ehab072"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD. Updates in cardiac amyloidosis: A review. J Am Heart Assoc 2012; 1: e000364.","DOI":"10.1161\/JAHA.111.000364"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tahara N, Lairez O, Endo J, et al. <sup>99m<\/sup>Technetium-pyrophosphate scintigraphy: A practical guide for early diagnosis of transthyretin amyloid cardiomyopathy. ESC Heart Fail 2022; 9: 251&ndash;62.","DOI":"10.1002\/ehf2.13693"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Treibel TA, Fontana M, Gilbertson JA, et al. Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: Prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging 2016; 9: e005066.","DOI":"10.1161\/CIRCIMAGING.116.005066"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dorbala S, Ando Y, Bokhari S, et al. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2&mdash;evidence base and standardized methods of imaging. Circ Cardiovasc Imaging 2021; 14: e000029.","DOI":"10.1161\/HCI.0000000000000029"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kittleson MM, Ruberg FL, Ambardekar AV, et al. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: A report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2023; 81: 1076&ndash;126.","DOI":"10.1016\/j.jacc.2022.11.022"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kitaoka H, Izumi C, Izumiya Y, et al. JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis. Circ J 2020; 84: 1610&ndash;71.","DOI":"10.1253\/circj.CJ-20-0110"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016; 133: 2404&ndash;12.","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Castano A, Haq M, Narotsky DL, et al. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: Predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol 2016; 1: 880&ndash;9.","DOI":"10.1001\/jamacardio.2016.2839"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Perugini E, Guidalotti PL, Salvi F, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using <sup>99m<\/sup>Tc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 2005; 46: 1076&ndash;84.","DOI":"10.1016\/j.jacc.2005.05.073"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Asif T, Gomez J, Singh V, Doukky R, Nedeltcheva A, Malhotra S. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls. J Nucl Cardiol 2021; 28: 104&ndash;11.","DOI":"10.1007\/s12350-020-02328-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dorbala S, Ando Y, Bokhari S, et al. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2&mdash;diagnostic criteria and appropriate utilization. Circ Cardiovasc Imaging 2021; 14: e000030.","DOI":"10.1161\/HCI.0000000000000030"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Poterucha TJ, Elias P, Bokhari S, et al. Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate: A test in evolution. JACC Cardiovasc Imaging 2021; 14: 1221&ndash;31.","DOI":"10.1016\/j.jcmg.2020.08.027"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Suenaga H, Fukushima K, Ishii S, et al. Global and regional reduction of myocardial perfusion in patients with transthyretin type of cardiac amyloidosis. Ann Nucl Cardiol 2023; published online. doi: 10.17996\/anc.23-00009","DOI":"10.17996\/anc.23-00009"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bokhari S, Casta&ntilde;o A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. <sup>99m<\/sup>Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 2013; 6: 195&ndash;201.","DOI":"10.1161\/CIRCIMAGING.112.000132"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hutt DF, Quigley AM, Page J, et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Heart J Cardiovasc Imaging 2014; 15: 1289&ndash;98.","DOI":"10.1093\/ehjci\/jeu107"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Saitou T, Aikawa T, Manabe O, Nagase A, Kudo T, Oyama-Manabe N. Comparison of 1-h with 3-h planar <sup>99m<\/sup>Tc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard. Ann Nucl Med 2023; 37: 99&ndash;107.","DOI":"10.1007\/s12149-022-01807-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sperry BW, Gonzalez MH, Brunken R, Cerqueira MD, Hanna M, Jaber WA. Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis. J Nucl Cardiol 2019; 26: 1630&ndash;7.","DOI":"10.1007\/s12350-017-1166-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hu LH, Kuo Y, Chang FP, et al. Hyperphosphatemia-related false-positive <sup>99m<\/sup>Tc-pyrophosphate myocardial scan: A case report with endomyocardial biopsy result. Clin Nucl Med 2023; 48: e544&ndash;6.","DOI":"10.1097\/RLU.0000000000004869"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wells RG, Ruskin JA, Sty JR. Myocardial imaging. Coxsackie myocarditis. Clin Nucl Med 1986; 11: 661&ndash;2.","DOI":"10.1097\/00003072-198609000-00017"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Khalaf S, Khan N, Al-Mallah M, Kassi M, Shah D. A positive PYP scan: Thinking beyond amyloid. J Nucl Cardiol 2021; 28: 1796&ndash;7.","DOI":"10.1007\/s12350-020-02149-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. El-Tallawi KC, Parikh R, Nabi F, Maclayton PI, Trachtenberg BH, Al-Mallah M. A positive Tc-99m PYP scan in a patient with cardiac sarcoidosis. J Nucl Cardiol 2021; 28: 2390&ndash;94.","DOI":"10.1007\/s12350-020-02158-5"}],"container-title":["Annals of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/anc\/10\/1\/10_24-00001\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T04:09:42Z","timestamp":1730520582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/anc\/10\/1\/10_24-00001\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.17996\/anc.24-00001","relation":{},"ISSN":["2189-3926","2424-1741"],"issn-type":[{"value":"2189-3926","type":"print"},{"value":"2424-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"24-00001"}}